Autoantibodies to nucleolar components are a common serological feature of patients suffering from scleroderma, a collagen vascular autoimmune disease. While animal models, which spontaneously develop abundant antinucleolar antibodies, have not yet been described, high titers of such antibodies may be induced by treating susceptible strains of mice with mercuric chloride. We have identified the nucleolar autoantigen against which the HgCI2-induced IgG autoantibodies from mice of strain B10.S are directed. It is a protein with an apparent molecular mass of 36 kDa and a pI value of =8.6, which is associated with the nucleolar small nuclear RNA U3, and by these criteria must be identical with a polypeptide called fibrillarin. It is striking that scleroderma patients spontaneously produce autoantibodies against the same U3 ribonucleoprotein (RNP). The HgCl2-induced murine and the scleroderma-specific human anti-U3 RNP autoantibodies were indistinguishable in their reactivities toward fibrillarin. They further resemble each other insofar as both recognize epitopes on the 36-kDa protein, which have been highly conserved throughout evolution. Our results provide a basis to investigate at the molecular level whether similar immunoregulatory dysfunctions may lead to the preferential anti-U3 RNP autoantibody production in the animal model and in scleroderma patients.
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Autoantibodies against the nucleolus are produced spontaneously by patients with collagen vascular diseases and, among such patients, are associated particularly with progressive systemic sclerosis (scleroderma) (1) (2) (3) . Sera from such patients stain nucleoli in distinctive patterns, indicating the presence of autoantibodies against a variety of nucleolar components. During recent years the identity of several of these nucleolar autoantigens has been described in molecular terms; they include the PM/Scl antigen (4, 5) , RNA polymerase I (6, 7), a 90-kDa protein of the nucleolus-organizing region (8) , as well as small nucleolar ribonucleoproteins (RNPs), the 7-2 RNP or To RNP (9, 10) , and the U3 small nuclear RNP (snRNP) (10) . Autoantibodies against U3 sn-RNP were shown to react with a basic protein of pI 8. 5 and with a molecular mass between 34 and 36 kDa (11, 12) . This protein was originally termed fibrillarin, since it is located in the fibrillar compartment of the nucleolus (13) .
Despite this progress in the characterization of the nucleolar autoantigens, little is known about the mechanisms that lead to formation of the anti-nucleolar autoantibodies. This might be due partly to the lack of appropriate animal models. While murine models, such as NZB/W, MRL/1, or BXSB mice, which spontaneously develop immunopathies resembling the human collagen vascular diseases, have contributed considerably to the understanding of various immunological abnormalities involved in the pathogenesis of these syndromes, production of anti-nucleolar autoantibodies is not a prominent feature of the spontaneous models.
In humans, some of the systemic autoimmune diseases can be induced by a number of drugs or chemicals. For instance, procainamide and hydralazine may cause a form of systemic lupus erythematosus (SLE) that resembles idiopathic SLE both clinically and serologically. Moreover, exposure to the occupational chemical vinyl chloride or the drug bleomycin can result in a disorder resembling idiopathic scleroderma. In both cases, a genetic predisposition appears to be necessary for induction of the pathological manifestations. For example, patients with vinyl chloride-induced scleroderma show an elevated frequency of HLA-DR5 and an increased linkage disequilibrium between HLA-B8 and HLA-DR3 similar to idiopathic scleroderma patients (14) .
From the use of mercury as a constituent of certain drugs and cosmetics and from occupational exposure it is known that subtoxic amounts of mercurials can cause immune complex glomerulonephritis in humans (15, 16) . In susceptible strains of rat (17) (18) (19) , subtoxic doses of mercuric chloride (HgCl2) cause immune complex glomerulopathies (17) (18) (19) , often associated with autoantibodies to DNA and other anti-nuclear antigens (18, 20, 21) . When HgC12 was administered to susceptible strains of mice, the' developed high titers of autoantibodies against nucleolar a, igens (22) (23) (24) . In highly susceptible mouse strains, such a, 310.S, this was accompanied by granular deposits of IgG in le glomeruli and vessel walls (24) similar to the picture seen in scleroderma.
The response to treatment with HgCI2 is determined by at least two different loci, one of which is located in H-2, the murine major histocompatibility complex: the haplotype H-2s encodes susceptibility, while H-2a and H-2d determine resistance (23, 24 Indirect Immunofluorescence. Immunofluorescence studies with mouse sera were performed either on unfixed cryostat sections (4 ,um thick) of liver tissue from a rabbit or on mouse 3T3 fibroblasts grown on coverslips and fixed by methanol and acetone as described (25) .
Immunoblot. A nuclear extract of HeLa S3 or Ehrlich ascites tumor cells was prepared and used for immunoblotting studies essentially as described (26) . Affinity purification of mouse antibodies on preparative immunoblots of total nuclear proteins from HeLa cells was carried out as described by Smith and Fisher (27) .
Two-Dimensional Gel Electrophoresis and Double-Label Immunoblot. HeLa nuclei were isolated and digested by RNase A and DNase 1 (26) . Proteins were precipitated with acetone and subjected to nonequilibrium pH gradient gel electrophoresis in the first dimension (28) and to electrophoresis in a 15% SDS/polyacrylamide gel in the second dimension. The proteins in the gel were transferred electrophoretically to nitrocellulose, on which they were visualized by Ponceau S (Serva) so that the position of the major heterogeneous nuclear RNP proteins Al, A2, Bla, Blb, and B2 could be identified. The antibody reaction was performed as described above for one-dimensionally separated proteins.
Immunoprecipitation, 3'-End Labeling, and Urea Gel Electrophoresis. A cell extract (low speed) was prepared from HeLa S3 cells essentially as described by Parker and Steitz (12) except that the cells were sonicated in NE-4 (10 mM Tris HCl, pH 7.4/100 mM NaCl/l mM MgCl2/i mM phenylmethylsulfonyl fluoride/i mM dithioerythritol) at a density of 1 x 108 cells per ml. Alternatively, the HeLa cell extract (high speed) was freed from preribosomal particles by an additional centrifugation at 120,000 x g for 2 hr (10). The procedure of immunoprecipitation was based on that of Matter et al. (29) .
Protein A-Sepharose CL-4B (2 ,ug) (Pharmacia), preswollen in 500 ,ul of NET-2 (40 mM Tris-HCI, pH 7.5/150 mM NaCl/ 0.05% Nonidet P-40), was incubated with 10 ,ul of ammonium sulfate-fractionated serum overnight at 4°C and then washed three times with NET-2. The antibody-bound beads were then incubated for 2 hr at 4°C with 100 ,ul of the cell extract and 400 ,ul of NET-2. After six washes with NET-2, the beads were extracted with phenol and the nucleic acids were precipitated by ethanol and either directly 3'-end-labeled with [32P]pCp and RNA ligase (30) Hg/m/n, serum sample of mouse no. m treated for n weeks with HgCl2; Na/m/n, serum sample from a mouse treated with sodium chloride as a control. mass of the U3 RNP protein (34-36 kDa), against which scleroderma sera react (see Introduction), suggested that HgCl2 treatment of mice induces anti-U3 RNP autoantibody formation. This possibility was investigated in more detail. First it was shown that a serum from a scleroderma patient termed S4 and previously shown to react with the U3 RNP protein fibrillarin (31) decorated a single protein band of the same molecular mass as the mouse sera (Fig. 2) .
We next compared the antigen reactivity of the sera from HgCl2-treated mice and patient serum S4 in two-dimensional immunoblots. As demonstrated in Fig. 4 , the two kinds of sera decorate indistinguishably the same protein with an apparent pI value of8.6 and molecular mass 36 kDa (compare Fig. 4 A and B for the mouse and human sera, respectively). In fact, the double-label immunoblot, in which human and murine autoantibodies were allowed to react simultaneously with the two-dimensionally separated nuclear proteins, only decorated a single antigenic polypeptide with an apparent pI value of 8.6; this was irrespective of the order of addition of anti-mouse phosphatase and anti-human peroxidase antibodies used for displaying the autoantibody reaction (data not shown). The physicochemical characteristics of the protein recognized by the mouse and human sera, as determined by our gel systems, closely agree with those described for the isolated U3 RNP protein fibrillarin (34 kDa, pI 8.5). Therefore, these data indicated that the experimentally induced autoantibodies were directed against the nucleolar protein fibrillarin. The above hypothesis was finally confirmed by radioimmunoprecipitation analysis. It has previously been shown that the anti-fibrillarin autoantibodies from scleroderma patients precipitate the nucleolar U3 RNP particle, demonstrating the association of this polypeptide with U3 RNA (11, 12) . When cellular extracts from HeLa cells were allowed to react with high-titered anti-nucleolar antisera from HgCl2-treated B1O.S mice, U3 RNP was found in the immunoprecipitate (Fig. SA,  lanes 2 and 3) , as would be anticipated for anti-fibrillarin autoantibodies.
Interestingly, various other RNAs were found in the immunoprecipitates obtained with the anti-nucleolar mouse antisera, in addition to U3 RNA (Fig. 5, lanes 2 and 3) . This coprecipitation with U3 RNP of the other RNA molecules cannot be due to nonspecific interactions, since the mouse control sera do not display such immunoprecipitates (Fig. SA,  lanes 4 and 5) . Furthermore, the same set of RNA molecules, in addition to U3 RNA, is also observed in the respective immunoprecipitate when anti-fibrillarin autoantibodies from scleroderma patient S4 reacted with HeLa cell extracts (lane 6). 3) and a low-speed (lanes 2 and 4) HeLa cell extract obtained with Hg-induced autoantibodies from BMO.S mice (lanes 1 and 2) or with sera from B10.S mice mock-injected with NaCl (lanes 3 and 4) were reprecipitated by anti-m3G IgG, 3'-end-labeled, and electrophoretically separated. Lane 5, 3'-end-labeled RNAs, which were precipitated from the total RNA of the high-speed extract by the anti-m3G antibody.
human anti-fibrillarin autoantibodies is, at least in part, a component of preribosomal assembly intermediates, which is in accordance with previous observations (10) . When the HeLa cell extract was freed from ribosomal particles by a high-speed centrifugation step at 120,000 x g for 2 hr (10), U3 RNP could still be precipitated efficiently by the mouse anti-fibrillarin autoantisera, indicating that a major part of U3 RNA is associated with the 36-kDa protein as free RNP particle in the cell extract (compare lanes 1 and 2 in Fig. SB ). This agrees with the findings of Parker and Steitz (12) .
In the experiments shown in Fig. SB , the immunoprecipitates obtained with the mouse sera were treated with phenol and the deproteinized RNAs were reprecipitated with anti-m3G antibodies. It is therefore interesting that, in addition to U3 RNA, two further RNA species were found in the immunoprecipitates that migrate in a similar way to, but clearly distinct from, the nucleoplasmic snRNAs U4 and U6 (Fig. SB) . By the criterion of reactivity with anti-m3G antibodies, these RNAs must contain 5'-terminal m3G cap structures. While we cannot rigorously exclude the possibility that they are 5'-terminal degradation products from U3 RNA, the fact that they were observed reproducibly at similar abundance irrespective of the anti-36-kDa autoantisera used for the immunoprecipitation (i.e., various mouse and human autoantisera) does not support this possibility.
DISCUSSION
Several lines of evidence demonstrate that injection of B10.S mice with HgCl2 results in production of IgG autoantibodies against the 36-kDa protein fibrillarin of U3 snRNP. On immunoblots, the mouse sera stain a protein with an apparent molecular mass of 36 kDa and an apparent pI value of 8.6, very close to the properties of the isolated U3 RNP protein (11, 12) . Furthermore, upon reaction with cellular extracts, the mouse sera precipitate U3 RNPs (Fig. 5) . In fact, the behavior of the HgCl2-induced immune sera in immunoblot and immunoprecipitation is indistinguishable from a human scleroderma serum, which has previously been characterized as being monospecific for fibrillarin (31) and was used as a positive control serum (Figs. 2, 4, and 5) .
At the present, we cannot exclude the possibility that, in addition to anti-nucleolar autoantibodies, HgCl2-treated B10.S mice also produce other autoantibodies. Clearly, however, anti-U3 RNP antibodies dominate the autoimmune response of these mice. This is indicated by our finding that the strength of the nucleolar immunofluorescence of individual mouse sera closely correlated with the intensity by which they stained the 36-kDa protein in the immunoblot. Furthermore, mouse autoantibodies that had been eluted from the 36-kDa protein on preparative immunoblots specifically stained the nucleoli in the immunofluorescence assay (Fig. 3) . How can we explain this surprisingly selective autoantibody production in B10.S mice by HgC12? At least three mechanisms may be considered, which are not mutually exclusive.
(i) The 36-kDa protein may specifically be modified by HgCl2 and thus rendered "foreign" to T lymphocytes.
(ii) HgCl2 is known to exert a direct stimulating effect on T helper cells, the mechanism ofwhich is not understood (33) (34) (35) . The (37) .
(iii) HgCl2 might directly modify major histocompatibility complex class II molecules of B10.S mice. This possibility is consistent with the fact that HgCl2 can be a contact sensitizer (38, 39) , implying that it creates a specific epitope seen by T cells. This mechanism, too, would result in a stimulation of T helper cells, which in turn might preferentially activate fibrillarin-specific B cell, as described in ii. In the latter two cases (ii and iii), helper T cells would cooperate with the autoreactive B cells via a "noncognate" mechanism, and we still have to settle the question of which structural features render the unmodified 36-kDa protein particularly active for autoimmunization, a question that must be answered to explain the preferential triggering of fibrillarin-specific B cells. In chronic graft versus host disease, both the structure and the available concentration of self-antigen appear to account for the preferential triggering of only certain autoreactive B cells by noncognate T-cell-B-cell collaboration (37, 40) .
Recently, Hultman and Enestrom (41) mesangium, the walls of their glomerular capillaries, and other blood vessel walls (42) .
It is striking that HgCl2 induces autoantibody production against the same nucleolar antigen against which autoantibodies are being produced spontaneously by patients suffering from idiopathic scleroderma. Both the murine and human autoantibodies are directed against evolutionarily highly conserved regions on the fibrillarin protein. Thus, not only do scleroderma patient anti-U3 RNP antisera react with the respective antigen from species as diverse as vertebrates (13) , plants (43) , and yeast (44) , but the HgCl2-induced mouse anti-U3 RNP antibodies react with all these as well (unpublished observations). A comparative analysis of the autoimmunizing B-cell epitopes and of the T-cell epitopes in the two systems will be necessary to see whether environmental toxins, such as mercurials, may be a cause of the autoantibody production seen in scleroderma patients. 
